IMVT Operating Cash Flow (Statement)
Immunovant Inc · Operating Cash Flow (Statement)
IMVT Operating Cash Flow (Statement)
Latest reported-$414.30Mperiod ending
IMVT Cash from Operations (-$128.30M → -$414.30M)
Annual operating cash flow (statement)
High-resolution chart · PNG
IMVT operating cash flow (statement) history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -407,310,000 | |
| -375,874,000 | |
| -214,227,000 | |
| -188,193,000 | |
| -106,112,000 | |
| -83,327,000 | |
| -53,357,000 | |
| -28,547,000 | |
| -128,297,000 |